Market: NMS |
Currency: USD
Address: 11682 El Camino Real
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for the emergency treatment of Type I allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
📈 ARS Pharmaceuticals, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$27.00
-
Upside/Downside from Analyst Target:
164.45%
-
Broker Call:
12
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
<0%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
<0%
-
Upcoming Earnings Date:
2026-05-14
-
EPS Estimate:
-0.55
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for ARS Pharmaceuticals, Inc.
| Date | Reported EPS |
|---|
| 2026-05-14 (estimated upcoming) | - |
| 2026-03-09 | -0.42 |
| 2025-11-10 | -0.52 |
| 2025-08-13 | -0.46 |
| 2025-05-14 | -0.35 |
| 2025-03-20 | 0.51 |
| 2024-11-13 | -0.2 |
| 2024-08-06 | -0.13 |
| 2024-05-09 | -0.11 |
| 2024-03-21 | -0.07 |
| 2023-11-09 | -0.16 |
| 2023-08-10 | -0.18 |
| 2023-05-15 | -0.16 |
| 2023-03-23 | -0.09 |
📰 Related News & Research
🔍 View more Reports
